The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

NCT03562169 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

406

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Ixazomib, thalidomide, & dexamethasone (ITD) re-induction
DRUG: Conventional autologous stem cell transplant (ASCT-con)
DRUG: Augmented autologous stem cell transplant (ASCT-aug)
DRUG: ITD consolidation and ixazomib maintenance vs. No further therapy

Sponsor

University of Leeds

Collaborators

[object Object]
[object Object]